4.4 Review

Human neuroimaging of oxytocin and vasopressin in social cognition

Journal

HORMONES AND BEHAVIOR
Volume 61, Issue 3, Pages 400-409

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yhbeh.2012.01.016

Keywords

Oxytocin; Vasopressin; Neuroimaging; Pharmacological fMRI; Imaging genetics; Social cognition; Amygdala; Human

Funding

  1. National Institute of Mental Health
  2. Deutsche Forschungsgemeinschaft (DFG) [SFB 636]
  3. Bundesministerium fur Bildung und Forschung (BMBF)
  4. National Alliance for Research on Schizophrenia and Depression (NARSAD)
  5. European Union

Ask authors/readers for more resources

The neuropeptides oxytocin and vasopressin have increasingly been identified as modulators of human social behaviors and associated with neuropsychiatric disorders characterized by social dysfunction, such as autism. Identifying the human brain regions that are impacted by oxytocin and vasopressin in a social context is essential to fully characterize the role of oxytocin and vasopressin in complex human social cognition. Advances in human non-invasive neuroimaging techniques and genetics have enabled scientists to begin to elucidate the neurobiological basis of the influence of oxytocin and vasopressin on human social behaviors. Here we review the findings to-date from investigations of the acute and chronic effects of oxytocin and vasopressin on neural activity underlying social cognitive processes using pharmacological fMRI and imaging genetics, respectively. This article is part of a Special Issue entitled Oxytocin, Vasopressin, and Social Behavior. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available